Last edition
News about "National Pharmaceutical Pricing Authority (NPPA) "
NPPA Fixes Retail Prices for 11 Drug Formulations Under DPCO 2013
The National Pharmaceutical Pricing Authority (NPPA) has issued a fresh notification fixing retail prices for multiple essential drug formulations—including antihypertensives, antibiotics, antidiabetics, and paediatric syrups—under the Drugs (Prices Control) Order, 2013. The revised prices apply to approved manufacturers and exclude GST.
National Pharmaceutical Pricing Authority (NPPA) | 02/12/2025 | By Dineshwori
AstraZeneca India Gets NPPA Show-Cause Notice Over Alleged Overcharging of Symbicort Turbuhaler
AstraZeneca Pharma India has received a show cause notice from the National Pharmaceutical Pricing Authority (NPPA) for allegedly overcharging on its Symbicort Turbuhaler Inhalation Powder (60 doses).
National Pharmaceutical Pricing Authority (NPPA) | 12/09/2025 | By Dineshwori | 125
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Intas Pharmaceuticals immunising agent immunoglobulin combination at 15 per cent higher than the existing human normal immunoglobulin solution for infusion 5%, since it is an incremental innovation having advantage without any increased side effect
National Pharmaceutical Pricing Authority (NPPA) | 08/03/2022 | By Darshana | 811
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy